
Epigenetics
Study of DNA modifications that do not change its sequence
The study of heritable phenotype changes that do not involve alterations in the DNA sequence.
MoreLatest News & Reports
Latest News
5Epigenetics-targeted drugs: current paradigms and future challenges
This review discusses the current landscape of epigenetic-targeted therapies, including ongoing clinical trials for drugs like PF-06821497. It highlights both the therapeutic potential in oncology and the challenges remaining for clinical implementation.
Johns Hopkins Researchers Develop Early Cancer Detection Method Based on Epigenetic Instability
Researchers at Johns Hopkins have developed a new method for early cancer detection that utilizes markers of epigenetic instability. This advancement represents a significant step forward in diagnostic technology for oncology.
Epigenetic regulation of CD8+ T cell exhaustion: recent advances and update
This article explores how DNA methylation and histone modifications create stable chromatin landscapes that drive and maintain CD8+ T cell exhaustion. It highlights the critical role of epigenetic and transcriptional regulation in immune response modulation.
Towards a better understanding of epigenetics and dynamic gene silencing and reactivation
Researchers have identified a conserved family of proteins responsible for the dynamic activation and de-activation of genes. This discovery improves our understanding of how silenced genes can be reactivated through epigenetic mechanisms.
Targeting fetal hemoglobin induction in sickle cell anemia: Epigenetic and gene‑modifying therapeutic strategies
This review examines current epigenetic and gene-modifying strategies aimed at inducing fetal hemoglobin as a therapeutic approach for sickle cell anemia. It discusses the potential for these methods to improve patient outcomes.
Rate This
once per dayRating Insights
No ratings yet. Be the first to rate this subject and start the trend.
Rating Over Time
Comments
0Create a free account to share your thoughts
No comments yet. Be the first to share your thoughts!
